Related Experiment Video
Updated: May 22, 2026
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Whole-genome sequencing in personalized therapeutics
1Program in Biomedical Informatics, Stanford University, Stanford, California, USA.
Clinical Pharmacology and Therapeutics
|May 3, 2012
Summary
Whole-genome sequencing is increasingly used for personalized medicine, offering new diagnostic and therapeutic options. Overcoming scientific, medical, and legal challenges is crucial for fully realizing its clinical potential.
Area of Science:
- Genomics
- Personalized Medicine
- Clinical Diagnostics
Background:
- The human genome draft publication paved the way for clinical applications of whole-genome sequencing.
- Decreasing sequencing costs and technological advancements accelerate the integration of genetic profiles into healthcare.
Purpose of the Study:
- To review current methods for decoding whole genomes in clinical settings.
- To provide examples of translating genomic data into actionable therapeutic knowledge.
- To identify challenges hindering the full exploitation of genomic data for personalized medicine.
Main Methods:
- Review of current whole-genome sequencing approaches for clinical use.
- Analysis of existing case studies linking genomic information to therapy.
- Identification of scientific, medical, legal, and management hurdles.
Main Results:
- Early successes demonstrate the application of whole-genome sequencing in personalized diagnosis and therapeutics.
- The potential for widespread clinical use is high due to declining costs and improving technologies.
- Significant challenges remain in data interpretation and implementation.
Conclusions:
- Whole-genome sequencing holds immense promise for advancing personalized medicine.
- A multidisciplinary approach involving science, medicine, law, and management is essential.
- Addressing current challenges is critical to fully leverage genomic data for improved patient outcomes.
Related Concept Videos
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...